Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Townsend

Showing results (111-120 of 250) with videos related to

Pageof 25
Sort By:
Biochimica Et Biophysica Acta|August 23, 1978
Conformation of pyridazine nucleosides: the molecular structure of 4-hydroxy-1-(beta-D-ribofuranosyl)pyridazin-6-one (3-deaza-6-azauridine)B J Graves, D J Hodgson, D J Katz, et al.
Journal of Medicinal Chemistry|July 1, 1991
Synthetic approaches to the guanosine and xanthosine analogues 5-amino-3-beta-D-ribofuranosylpyrazolo[3,4-e][1,3]oxazin-7-one and 3-beta-D-ribofuranosylpyrazolo[3,4-e][1,3]oxazine-5,7-dione and studies of their antitumor potentialR M Zou, V G Beylin, M P Groziak, et al.
Environmental Science & Technology|November 6, 2014
Modeling nonequilibrium adsorption of MIB and sulfamethoxazole by powdered activated carbon and the role of dissolved organic matter competitionKyle K Shimabuku, Hyukjin Cho, Eli B Townsend, et al.
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and evaluation of 6-(dibromomethyl)-5-nitropyrimidines as potential antitumor agentsM D Thompson, T L Cupps, D S Wise, et al.
Journal of Medicinal Chemistry|October 1, 1981
Pyrazolopyrimidine nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]pyrimidine nucleosides related to adenosineG A Bhat, J L Montero, R P Panzica, et al.
Cancer Treatment Reports|April 1, 1986
Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCNL L Wotring, G W Crabtree, N L Edwards, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activityDavid L Evers, Julie M Breitenbach, Katherine Z Borysko, et al.
Journal of Neurodevelopmental Disorders|October 20, 2020
Deficits in higher visual area representations in a mouse model of Angelman syndromeLeah B Townsend, Kelly A Jones, Christopher R Dorsett, et al.
Journal of Medicinal Chemistry|May 9, 1998
Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazoleA R Porcari, R V Devivar, L S Kucera, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|April 12, 2022
Comprehensive Analysis of Opioid Use After Common Elective Outpatient Orthopaedic SurgeriesMichael U Okoli, Alexander J Rondon, Clay B Townsend, et al.
Pageof 25

Showing results (111-120 of 250) with videos related to

Sort By:
Pageof 25
Biochimica Et Biophysica Acta|August 23, 1978
Conformation of pyridazine nucleosides: the molecular structure of 4-hydroxy-1-(beta-D-ribofuranosyl)pyridazin-6-one (3-deaza-6-azauridine)B J Graves, D J Hodgson, D J Katz, et al.
Journal of Medicinal Chemistry|July 1, 1991
Synthetic approaches to the guanosine and xanthosine analogues 5-amino-3-beta-D-ribofuranosylpyrazolo[3,4-e][1,3]oxazin-7-one and 3-beta-D-ribofuranosylpyrazolo[3,4-e][1,3]oxazine-5,7-dione and studies of their antitumor potentialR M Zou, V G Beylin, M P Groziak, et al.
Environmental Science & Technology|November 6, 2014
Modeling nonequilibrium adsorption of MIB and sulfamethoxazole by powdered activated carbon and the role of dissolved organic matter competitionKyle K Shimabuku, Hyukjin Cho, Eli B Townsend, et al.
Journal of Medicinal Chemistry|February 28, 1997
Synthesis and evaluation of 6-(dibromomethyl)-5-nitropyrimidines as potential antitumor agentsM D Thompson, T L Cupps, D S Wise, et al.
Journal of Medicinal Chemistry|October 1, 1981
Pyrazolopyrimidine nucleosides. 12. Synthesis and biological activity of certain pyrazolo[3,4-d]pyrimidine nucleosides related to adenosineG A Bhat, J L Montero, R P Panzica, et al.
Cancer Treatment Reports|April 1, 1986
Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCNL L Wotring, G W Crabtree, N L Edwards, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activityDavid L Evers, Julie M Breitenbach, Katherine Z Borysko, et al.
Journal of Neurodevelopmental Disorders|October 20, 2020
Deficits in higher visual area representations in a mouse model of Angelman syndromeLeah B Townsend, Kelly A Jones, Christopher R Dorsett, et al.
Journal of Medicinal Chemistry|May 9, 1998
Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazoleA R Porcari, R V Devivar, L S Kucera, et al.
Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews|April 12, 2022
Comprehensive Analysis of Opioid Use After Common Elective Outpatient Orthopaedic SurgeriesMichael U Okoli, Alexander J Rondon, Clay B Townsend, et al.
Pageof 25